Award notice, total small business set-aside, first published as combined synopsis and solicitation
Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract
75F40124R00064
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
Tranquil Clinical and Research Consulting Services LLC
$50,000,000.00 on the award notice, September 15, 2025, contract 75F40125D00003
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2024
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Development/Production - Kidney GEC-Specific AAV Vector
Department of Veterans Affairs, Rpo East
Sources soughtNAICS 541714Columbia, MO36C24E27Q0009Closes in 3 daysNov 4 - AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 4 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 5 daysNov 5
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
This is a commercial services Food and Drug Administration (FDA) open market single-award Indefinite Delivery-Indefinite Quantity (IDIQ) type contract set aside 100% for small business. The scope of activities FDA may require of the contractor shall include the capability to conduct multiple Phase I clinical trials within a year and at times in parallel, and the provision of a full range of services to support the clinical trials and reporting of the results. The Authorized Task Order (TO) type under this IDIQ contract is Firm-Fixed-Price (FFP).
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- UEI
- FWWJT8QCEDY4
- CAGE
- 9Z4C3
- Vendor location
- Webster, TX
- Contract
- 75F40125D00003
- Obligated
- $2,500.00, potential $50,000,000
- Actions
- 2 between September 15, 2025 and October 20, 2025
- Competition
- Full and Open Competition After Exclusion of Sources, 3 offers received
- Set-aside reported
- Small Business Set Aside - Total
- Described as
- FFP - Single Award IDIQ - Cder - Office of Clinical Pharmacology Clinical Studies and Laboratory Support
- Match
- award number 75F40125D00003 equals the contract number; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 18, 2024
Combined synopsis and solicitation, originally sources sought
Due September 2, 2024 at 3:00 PM EDT. SAM.gov, notice bc5a92457170469197e4dd89369a8bfd
August 15, 2024
Combined synopsis and solicitation
Due September 2, 2024 at 3:00 PM EDT. SAM.gov, notice 7241338dfc21472a8dc4cdf40e091aa7
September 16, 2025
Award notice, originally combined synopsis and solicitation
Awarded to Tranquil Clinical and Research Consulting Services LLC for $50,000,000. SAM.gov, notice b5f18d924b64480295b9816059860a6e
2 revisions on SAM
- September 16, 2025: publish, award notice
- August 15, 2024: publish, combined synopsis and solicitation
Points of contact
- Craig Wrightcraig.wright@fda.hhs.gov240-402-3996
- Ian WeissIan.Weiss@fda.hhs.gov3017965728